Identification of a Novel Mechanism for Endotoxin-mediated Down-modulation of CC Chemokine Receptor Expression
Overview
Authors
Affiliations
In the present study, we explored the molecular mechanisms by which bacterial endotoxin (LPS) mediates the down-regulation of CCR2 receptors on human monocytes. We found that LPS induced a marked reduction in CCR2 cell surface protein levels which was blocked by pretreatment with the tyrosine kinase inhibitors genistein and herbimycin A. The effector mechanism underlying LPS-induced CCR2 down-modulation appears to involve the enzymatic activity of proteinases since Western blot analysis of LPS-stimulated monocytes revealed the degradation of a 38-kDa species corresponding to the CCR2B monomer. In RBL cells expressing the CCR2B-green fluorescent protein (GFP) fusion chemokine receptor, LPS stimulated the internalization and degradation of CCR2. The serine proteinase inhibitor N-alpha-p-tosyl-L-lysine chloromethyl ketone blocked LPS-induced down-modulation of CCR2 in monocytes and CCR2B-GFP in RBL cells. This work describes a previously uncharacterized mechanism for CC chemokine receptor down-modulation that is dependent upon tyrosine kinase activation and serine proteinase-mediated receptor degradation and may provide further insight into the mechanisms of leukocyte regulation during immunological and inflammatory responses.
Heterogeneity of Bovine Peripheral Blood Monocytes.
Hussen J, Schuberth H Front Immunol. 2018; 8:1875.
PMID: 29312348 PMC: 5742132. DOI: 10.3389/fimmu.2017.01875.
Kumase F, Takeuchi K, Morizane Y, Suzuki J, Matsumoto H, Kataoka K PLoS One. 2016; 11(1):e0147279.
PMID: 26799633 PMC: 4723067. DOI: 10.1371/journal.pone.0147279.
Rowley S, Kuriakose T, Dockery L, Tran-Nguyen T, Gingerich A, Wei L J Biol Chem. 2014; 289(22):15788-97.
PMID: 24713702 PMC: 4140933. DOI: 10.1074/jbc.M114.559344.
Calcitonin gene-related peptide regulates type IV hypersensitivity through dendritic cell functions.
Mikami N, Sueda K, Ogitani Y, Otani I, Takatsuji M, Wada Y PLoS One. 2014; 9(1):e86367.
PMID: 24466057 PMC: 3897726. DOI: 10.1371/journal.pone.0086367.
Bachelerie F, Ben-Baruch A, Burkhardt A, Combadiere C, Farber J, Graham G Pharmacol Rev. 2013; 66(1):1-79.
PMID: 24218476 PMC: 3880466. DOI: 10.1124/pr.113.007724.